摘要 |
The invention relates to antibiotic derivatives of formula I wherein: A represents -O-, S, -C(-O)-, -C(-NOR<SUP>6</SUP>)-; Z-B represents NCH<SUB>2</SUB>CH<SUB>2</SUB>, NCOCH<SUB>2</SUB>, NCH<SUB>2</SUB>CO, NCH<SUB>2</SUB>CH(OH), CHN(R<SUP>8</SUP>)CH<SUB>2 </SUB>or CHN(R<SUP>8</SUP>)CO; D represents binuclear heteroaryl; Y<SUP>1 </SUP>represents -CR<SUP>1</SUP>- or -N-, Y<SUP>2 </SUP>represents -CR<SUP>2</SUP>- or -N-, Y<SUP>3 </SUP>represents -CR<SUP>3</SUP>- or -N- and Y<SUP>4 </SUP>represents -CR<SUP>4</SUP>- or -N-; U represents -NH-, -O- or -S- and V represents -N- or -CH-; W represents -CH<SUB>2</SUB>-, -O- or -NR<SUP>7</SUP>-; R<SUP>1 </SUP>represents H, methyl, ethyl or halogen; R<SUP>2</SUP>, R<SUP>3 </SUP>and R<SUP>4 </SUP>each represent independently H, C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, halogen, or C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxy; R<SUP>5 </SUP>represents H, C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl or fluorine; R<SUP>6 </SUP>represents H, C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl or aryl-C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; R<SUP>7 </SUP>represents H, C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, aryl-C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl or -CH<SUB>2</SUB>-COOH; R<SUP>8 </SUP>represents H, C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl or -CH<SUB>2</SUB>-COOH; with the provisos that if Z-B represents NCH<SUB>2</SUB>CH<SUB>2</SUB>, NCOCH<SUB>2</SUB>, NCH<SUB>2</SUB>CO or NCH<SUB>2</SUB>CH(OH), then W represents -CH<SUB>2</SUB>-; if A represents O or S, then W represents -CH<SUB>2</SUB>-; and only one or two of Y<SUP>1</SUP>, Y<SUP>2</SUP>, Y<SUP>3 </SUP>and Y<SUP>4 </SUP>can represent N at the same time.
|